Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Appetite drug shows promise in treating obesity

By John Blundell, Professor of Psychobiology, University of Leeds
Share this article
A recently published clinical trial of the anti-obesity drug, semaglutide, has produced a degree of weight loss which has led some to dub the medication a “game changer” in the treatment of obesity.

The trial looked at 1,961 adults who were overweight or obese. Approximately 75% of participants were female. Participants were given a weekly injection of semaglutide, a drug normally used to control blood…


Read complete article

© The Conversation -


Follow us on ...
Facebook Twitter